Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Shandong Provincial Hospital | OTHER_GOV |
Not provided
Not provided
Not provided
Not provided
Glioma is the most common primary cancer of the central nervous system, and around 50% of patients present with the most aggressive form of the disease, glioblastoma. Conventional therapies, including surgery, radiotherapy, and pharmacotherapy (typically chemotherapy with temozolomide), have not resulted in major improvements in the survival outcomes with only a median survival of around 15 months.The main reason may be related to the highly immunosuppressive tumor microenvironment. In recent years, the microbiome has emerged as a key regulator of not only systemic immune regulation but brain circuitry, neuro-physiology and microglia development. We hypothesized that there is a link between the gut microbiota and the GBM development and evolution through the immune regulation cells (microglia and tumor related macrophagocyte) in the blood circulation to impact the prognosis( PFS and MST) of GBM patients.
We divide the paticipants into three groups. (total number = 200 subjects)
After the collection of stools before operation and 3 months after the operaton, we will analyze the composition and distribution of gut microbiota, and compare the results of three experiment groups.Then we will followe up the patients and analyze the correlation between gut microbiota and prognosis of GBM.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Radio/Chemotherapy group | The participants in this group receive the concurren radio/chemotrherapy |
| |
| Radio/ without chemotherapy group | The participants in this group receive the radiotherapy but without chemotrherapy |
| |
| Healthy volunteer group | The volunteers for control group |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Chemotherapy with temozolomide or no chemotherapy | Other | This study is just an observational study. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Pre-operative gut microbiota in molecular subtype glioblastoma mutiforme multiform | To analysis the distribution and components of gut microbiota before operation | 12 months |
| The perturbation of gut microbiota by temozolomide chemotherapy | To investigate the change of components of gut microbiota induced by chemotherapy | 15 months |
| Link the gut microbiota and prognosis of GBM | To explore the correlation between the gut micriobiota and the prognosis (PFS and MST) by bioinformatic big data process. | 20 months |
Not provided
Not provided
Inclusion Criteria:
The participants diagnosed with glioblastoma multiforme by immunohistochemistry and molecular (IDH1, 1p19q, TERT) diagnosis of WHO 2016 classification of Gliomas.
The healthy volunteers.
Exclusion Criteria:
Not provided
Not provided
The patients enrolled from neurosurgery department of Huashan hospital and the Shandong provincial hospital affiliated to Shandong University; while the healthy volunteers come from the health examination center of huashan hospital and Shandong provincial hospital affiliated to Shandong University.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Jinsong Wu, Ph.D. & M.D. | Contact | +86-52880000 | 7220 | wjsongc@126.com |
| Yingchao Liu, Ph.D. & M.D | Contact | +86-68776128 | +8652880000 | 13805311573@126.com |
| Name | Affiliation | Role |
|---|---|---|
| Jinsong Wu, Ph.D. & M.D | Huashan Hospital | Study Chair |
| Weifeng Shi, Ph.D. | Taishan Medical Univiersity | Principal Investigator |
| Yingchao Liu, Ph.D. & M.D |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D005909 | Glioblastoma |
| ID | Term |
|---|---|
| D001254 | Astrocytoma |
| D005910 | Glioma |
| D018302 | Neoplasms, Neuroepithelial |
| D017599 | Neuroectodermal Tumors |
Not provided
Not provided
| ID | Term |
|---|---|
| D004358 | Drug Therapy |
| D000077204 | Temozolomide |
| ID | Term |
|---|---|
| D013812 | Therapeutics |
| D003606 | Dacarbazine |
| D014226 | Triazenes |
| D009930 | Organic Chemicals |
Not provided
Not provided
Not provided
Not provided
Not provided
microbiota DNA are extracted from human feces.
| Shandong provincial hospirtal affiliated to Shandong University |
| Study Director |
| D009373 |
| Neoplasms, Germ Cell and Embryonal |
| D009370 | Neoplasms by Histologic Type |
| D009369 | Neoplasms |
| D009375 | Neoplasms, Glandular and Epithelial |
| D009380 | Neoplasms, Nerve Tissue |
| D007093 |
| Imidazoles |
| D001393 | Azoles |
| D006573 | Heterocyclic Compounds, 1-Ring |
| D006571 | Heterocyclic Compounds |